Halozyme (HALO) Debt/EBITDA US GAAP (year values) |
||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| Debt/EBITDA | 3.62 | 3.62 | 2.57 | 1.39 | -0.16 | -0.11 | ||
| Changes by years, y/y, % | +591% | 0% | -29% | -46% | -111% | |||
Halozyme. Debt/EBITDA
Halozyme. Debt/EBITDA, changes, %
Halozyme (HALO) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 1.10 | 1.23 | 0.98 | -0.16 | -0.11 | -0.11 | ||
| Changes by years, y/y, % | -48% | -35% | -33% | -111% | -110% | |||
| Changes by quarters, q/q, % | -22% | +13% | -21% | -116% | -28% | |||